Mike Owen, Chairman BHI: Mike has over 25 years’ research experience. In the last 20 years he has been Chairman of Context Research and more recently (since 2005) CEO of Brand Health International. During this time he has focussed heavily on Brands and Brand Development within the pharmaceutical industry and has written and presented many articles, papers and a book on this subject. Conference, Workshop presentations and papers include, amongst many others:

• 1986 (MRS): Award winning (Best Paper) paper on Gaming Techniques with Jon Chandler
• 1989 (BPMRG): Branding Drugs to meet the Generic Challenge
• 1990 (EphMRA): Workshop (Luxembourg) on International Brand Research with Catherine Ayland of Knoll Pharmaceuticals
• 1993 (EphMRA): Workshop (Amsterdam) on Use of Consumer Approaches in Pharmaceutical Research with Jon Chandler
• 1999 (EphMRA): ‘International Brand Building Research’, with Ian Becattelli and Mike Pepp
• 2001 (EphMRA): Workshop (Zurich) on International positioning (repeated in both 2002 and 2004)
• 2002 (EphMRA): Workshop in April on International branding
• 2003: Epilepsy – changing a market by use of the Advanced Brand model, Giles Moss and Mike Owen Published in: International Journal of Medical Marketing 2003.

In 2000 Mike was commissioned by SAGE (along with Jon Chandler also of BHI) to write an authoritative book on ‘Developing Brands through qualitative research’. This was published in 2002. The process of writing this book has led to the development of a range of research and analytic tools used in positioning and branding that are unique to BHI.

Giles D. Moss, MBA, MRPharmS, BSc, is a pharmaceutical industry insider who has risen through the ranks during a twenty year career. Starting as a Sales Representative at Squibb, he has gathered extensive sales and marketing experience (BMS, Sandoz, and SmithKline Beecham) in the UK before moving on into General Management. He works in Operations as Vice President Europe; Region 1 for UCB Pharma., a Belgium based global top five Biopharmaceutical Company

His product and launch management experience include Lipostat and the launch of Taxol at BMS, creation of the UK Stepwise (Lamisil) DTCa campaign whilst at Sandoz and managing Keppra as Head of CNS Global Marketing and Medical Affairs when it grew from $50m sales to $450m at UCB. His operational responsibilities include managing a portfolio of countries which contribute in excess of $300m revenues, and has held direct responsibility for 17 countries in South East Asia, Australia, New Zealand and Europe

He has published pharmaceutical brand articles in numerous publications including the Journal of Brand Management, the International Journal of Medical Marketing, and the Journal of Pharmaceutical Marketing & Management. His book "Pharmaceuticals – Where's the Brand Logic? Branding Lessons and Strategy" is now published in hardcover ($59.95) and soft cover ($32.95) and is available in quality US on-line bookstores, the European launch will occur at the end of the first quarter 2008.

Jon Chandler left academia and began his 25 year Market Research career in 1983. In 1986 he set up Context Research with Mike Owen, when Context became BHI, Jon became Managing Director in charge of Brand Creation. During this time he has been in charge of hundreds of consumer and healthcare projects, specialising in healthcare from the very early nineties.

Jon has played a wider role within the Market research industry. Jon served for five years as a member of the MRS professional standards committee, where he was specifically involved with the development of guidelines for the conduct of observational research and liased with the BHBIA in the development of market research guidelines covering the conduct of market research in the pharmaceutical arena.

Jon has been an active contributor to the theory of market research, beginning with a joint paper with Mike Owen in 1986 which won ‘Best Paper’ at the MRS conference. Jon Has continued to write and speak about Market research ever since, including since 2000:

• 2000 (MRI Pharma Conference): Superbranding: The Road to a Global View
• 2002 (BPMRG) Brand Innovation & the Factors of Change
• 2002 (International Journal of Market Research) Pharmaceuticals; The New Brand Arena
• 2002 (Sage, London) Developing Brands with Qualitative Market Research. Book written with Mike Owen as part of the Sage QMR series
• 2005 (MRS conference) Looking Backwards, Moving Forwards
• 2006 (EphMRA conference) Going Beyond Research As We Know It
• 2008 (BHBIA) The Empathy Gene.

Amber Gibson is a market research manager at Sanofi-Aventis, UK, where she is responsible for the primary and secondary market research within the diabetes portfolio. Prior to Sanofi Aventis, Amber worked in the market research department at Eli-Lilly (focusing on Strattera & Cialis and then Zyprexa) and as an analyst at Datamonitor. Amber also completed a PhD in Environmental Risk Management.